Juan Bi Tong Luo,a traditional Chinese medicine,ameliorates diabetic peripheral neuropathy by downregulating the MAPK/NF-κB signaling pathwayOA
Background:Inflammation,caused by prolonged hyperglycemia,plays a substantially more important part in the progression of diabetic peripheral neuropathy(DPN).Notably,the MAPK pathway that mediates the Nuclear Factor-kappa B(NF-κB)pathway contributes to inflammation-induced peripheral nerve damage,affecting cell survival.Juan Bi Tong Luo(JBTL),a traditional Chinese medicine(TCM),has demonstrated favorable results in alleviating pain and numbness in patients with DPN;however,whether JBTL exerts its effect through the MAPK mediating NF-κB pathway remains unclear.Methods:This study investigated whether JBTL modulates apoptosis in DPN models and Schwann cells cultured in 100 mM of glucose by MAPK/NF-κB.Results:The JBTL altered inflammation,reduced peripheral nerve tissue damage,and improved cell survival rates by down-regulating MAPK/NF-κB.Conclusion:Our findings demonstrate that the effect of JBTL on DPN is likely mediated by suppressing inflammation induced by the MAPK/NF-κB pathway,thus providing evidence for the clinical efficacy of JBTL in treating DPN.
Wei Liu;Yue Zhu;Wei Song;Fei Huang
Department of endocrinology,Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine,Suzhou 215009,ChinaSchool of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210029,ChinaDepartment of Dermatology,the Fifth People’s Hospital of Suzhou,Suzhou 215009,ChinaDepartment of endocrinology,Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine,Suzhou 215009,China
医药卫生
Juan Bi Tong Luodiabetic peripheral neuropathyinflammation
《Traditional Medicine Research》 2026 (3)
P.56-64,9
funded by grants from the Suzhou Gusu Health Talents Project(grant No.GSWS2024050 to Liu W)Natural Science Foundation Project of Nanjing University of Chinese Medicine(grant No.XZR2021043 to Liu W and grant No.XZR2023021 to Huang F)Suzhou Science Education Health Youth Project(grant No.KJXW2021046 to Liu W)Suzhou Major Disease Multi-center Clinical Research Project(grant No.DZXYJ202410 to Huang F).
评论